Genomic Health, Inc. (GHDX) Reports Q4 loss of 30c, Offers Guidance
Tweet Send to a Friend
Genomic Health, Inc. (NASDAQ: GHDX) reported Q4 EPS of ($0.30), $0.27 worse than the analyst estimate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
